[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610232":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":34,"collaborators":7,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"HemoCept Inc.","INDUSTRY",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Katharine Adkins","CONTACT","303-442-2395","kathari.adkins@bch.org",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"Boulder Heart","RECRUITING","Boulder","Colorado","80303","United States","US",{"type":24,"coordinates":25},"Point",[26,27],-105.27055,40.01499,{"lat":27,"lon":26},[30,31],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"name":32,"role":33,"phone":7,"phoneExt":7,"email":7},"Scott Blois, MD","PRINCIPAL_INVESTIGATOR",{"type":35,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100610232","observational-study-of-patients-undergoing-diagnostic-right-heart-catheterization-100610232",false,"NCT07224906","Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization","Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart","Inclusion Criteria:\n\n* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.\n* Subjects can be any gender but must be age 18 or older.\n* Subject is able and willing to provide informed consent and HIPAA authorization.\n* Subject is able and willing to meet all study requirements.\n* Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)\n\nExclusion Criteria:\n\n* Subject is pregnant, breastfeeding, or intends to become pregnant during this study.","ALL","18 Years",{"count":46,"type":47},50,"ESTIMATED","OBSERVATIONAL","The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.",[51,52,53],"Pulmonary Hypertension","Congestive Heart Failure(CHF)","Valve Disease, Heart","2026-04-09",{"date":56,"type":57},"2026-04-13","ACTUAL",{"date":59,"type":57},"2025-12-01",{"date":61,"type":47},"2027-01",{"name":5,"class":6},1]